SMT201300101B - Un'emulsione del tipo acqua in olio per il trattamento di una malattia dell'occhio - Google Patents
Un'emulsione del tipo acqua in olio per il trattamento di una malattia dell'occhioInfo
- Publication number
- SMT201300101B SMT201300101B SM201300101T SM201300101T SMT201300101B SM T201300101 B SMT201300101 B SM T201300101B SM 201300101 T SM201300101 T SM 201300101T SM 201300101 T SM201300101 T SM 201300101T SM T201300101 B SMT201300101 B SM T201300101B
- Authority
- SM
- San Marino
- Prior art keywords
- composition
- water
- oil type
- emulsion
- phase
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10175337.4A EP2425814B1 (en) | 2010-09-03 | 2010-09-03 | A water-in-oil type emulsion for treating a disease of the eye |
Publications (1)
Publication Number | Publication Date |
---|---|
SMT201300101B true SMT201300101B (it) | 2013-11-08 |
Family
ID=43662067
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SM201300101T SMT201300101B (it) | 2010-09-03 | 2013-09-18 | Un'emulsione del tipo acqua in olio per il trattamento di una malattia dell'occhio |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP2425814B1 (xx) |
CY (1) | CY1114688T1 (xx) |
DK (1) | DK2425814T3 (xx) |
ES (1) | ES2426603T3 (xx) |
HR (1) | HRP20130830T1 (xx) |
PL (1) | PL2425814T3 (xx) |
PT (1) | PT2425814E (xx) |
SI (1) | SI2425814T1 (xx) |
SM (1) | SMT201300101B (xx) |
UA (1) | UA111168C2 (xx) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016005514A1 (en) | 2014-07-10 | 2016-01-14 | Stichting Katholieke Universiteit | Antisense oligonucleotides for the treatment of usher syndrome type 2 |
GB201503408D0 (en) | 2015-02-27 | 2015-04-15 | Proqr Therapeutics N V | Oligonucleotides |
WO2017060317A1 (en) | 2015-10-05 | 2017-04-13 | Proqr Therapeutics Ii B.V. | Use of single-stranded antisense oligonucleotide in prevention or treatment of genetic diseases involving a trinucleotide repeat expansion |
CN111840218B (zh) | 2016-03-16 | 2022-07-12 | 苏州澳宗生物科技有限公司 | 依达拉奉剂型 |
WO2017177265A1 (en) * | 2016-04-12 | 2017-10-19 | Capsular Technologies Pty Ltd | Injectable composition for delivery of a biologically active agent |
WO2017186739A1 (en) | 2016-04-25 | 2017-11-02 | Proqr Therapeutics Ii B.V. | Oligonucleotides to treat eye disease |
GB201616202D0 (en) | 2016-09-23 | 2016-11-09 | Proqr Therapeutics Ii Bv | Antisense oligonucleotides for the treatment of eye deisease |
WO2018109011A1 (en) | 2016-12-13 | 2018-06-21 | Stichting Katholieke Universiteit | Antisense oligonucleotides for the treatment of stargardt disease |
WO2020015959A1 (en) | 2018-07-19 | 2020-01-23 | Stichting Katholieke Universiteit | Antisense oligonucleotides rescue aberrant splicing of abca4. |
EP3891282A1 (en) | 2018-12-04 | 2021-10-13 | Stichting Katholieke Universiteit | Antisense oligonucleotides rescue aberrant splicing of abca4 |
CA3126371A1 (en) | 2019-01-28 | 2020-08-06 | Proqr Therapeutics Ii B.V. | Antisense oligonucleotides for the treatment of leber's congenital amaurosis |
WO2020212567A1 (en) | 2019-04-18 | 2020-10-22 | Proqr Therapeutics Ii B.V. | Antisense oligonucleotides for the treatment of usher syndrome |
CN110090225B (zh) * | 2019-04-19 | 2021-07-16 | 济南康和医药科技有限公司 | 一种依达拉奉氯化钠注射液及其制备方法 |
WO2021023863A1 (en) | 2019-08-08 | 2021-02-11 | Stichting Katholieke Universiteit | Antisense oligonucleotides rescue aberrant splicing of abca4 |
IT201900019190A1 (it) | 2019-10-17 | 2021-04-17 | Univ Politecnica Delle Marche | Derivato dell’epigallocatechina gallato |
CA3166720A1 (en) | 2020-03-04 | 2021-09-10 | Jim SWILDENS | Antisense oligonucleotides for use in the treatment of usher syndrome |
WO2022090256A1 (en) | 2020-10-26 | 2022-05-05 | Proqr Therapeutics Ii B.V. | Antisense oligonucleotides for the treatment of stargardt disease |
WO2024074670A1 (en) | 2022-10-06 | 2024-04-11 | Stichting Radboud Universitair Medisch Centrum | Antisense oligonucleotides for treatment of usher 2a. exon 68 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1318539B1 (it) | 2000-05-26 | 2003-08-27 | Italfarmaco Spa | Composizioni farmaceutiche a rilascio prolungato per lasomministrazione parenterale di sostanze idrofile biologicamente |
US6417237B1 (en) * | 2000-06-08 | 2002-07-09 | The Board Of Trustees Of The University Of Illinois | Macromolecular drug complexes and compositions containing the same |
EP1485066B1 (fr) * | 2002-03-12 | 2016-09-21 | Ethypharm | Composition a proprietes gelifiantes destinee a la delivrance prolongee de substances bio-actives |
EP1867323A1 (en) * | 2006-06-13 | 2007-12-19 | Farmatron Ltd. | Pharmaceutical compositions with biological barriers permeation enhancing properties |
US9125807B2 (en) | 2007-07-09 | 2015-09-08 | Incept Llc | Adhesive hydrogels for ophthalmic drug delivery |
US20110182877A1 (en) | 2007-10-02 | 2011-07-28 | Potentia Pharmaceuticals, Inc. | Sustained delivery of compstatin analogs from gels |
-
2010
- 2010-09-03 PL PL10175337T patent/PL2425814T3/pl unknown
- 2010-09-03 ES ES10175337T patent/ES2426603T3/es active Active
- 2010-09-03 EP EP10175337.4A patent/EP2425814B1/en active Active
- 2010-09-03 PT PT101753374T patent/PT2425814E/pt unknown
- 2010-09-03 DK DK10175337.4T patent/DK2425814T3/da active
- 2010-09-03 SI SI201030338T patent/SI2425814T1/sl unknown
-
2011
- 2011-02-09 UA UAA201302734A patent/UA111168C2/uk unknown
-
2013
- 2013-09-04 CY CY20131100763T patent/CY1114688T1/el unknown
- 2013-09-05 HR HRP20130830AT patent/HRP20130830T1/hr unknown
- 2013-09-18 SM SM201300101T patent/SMT201300101B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
EP2425814A1 (en) | 2012-03-07 |
PT2425814E (pt) | 2013-09-02 |
PL2425814T3 (pl) | 2013-11-29 |
UA111168C2 (uk) | 2016-04-11 |
SI2425814T1 (sl) | 2013-10-30 |
DK2425814T3 (da) | 2013-09-08 |
ES2426603T3 (es) | 2013-10-24 |
HRP20130830T1 (xx) | 2013-10-11 |
CY1114688T1 (el) | 2016-10-05 |
EP2425814B1 (en) | 2013-06-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SMT201300101B (it) | Un'emulsione del tipo acqua in olio per il trattamento di una malattia dell'occhio | |
MY157513A (en) | A water-in-oil type emulsion for treating a disease of the eye | |
AR121843A2 (es) | Formulación oftálmica y método para mejorar la presbicia | |
BRPI0607606A2 (pt) | formulações lìquidas para tratamento de doenças ou condições | |
BRPI0821683B8 (pt) | uso de um agonista parassimpático e de um antagonista simpático ou um agonista simpático para tratar presbiopia, miopia, hipermetropia, emetropia e/ou astigmatismo, e/ou para melhorar a visão noturna ou de baixa luz | |
MX2022007012A (es) | Uso de un agonista doble del receptor de glp-1/glucagon de larga accion para el tratamiento de la enfermedad de higado graso no alcoholico. | |
AR085662A1 (es) | Metodos y composiciones para tratar la hiperuricemia y trastornos metabolicos asociados con la hiperuricemia | |
EA201270221A1 (ru) | Лечение болезни крона с применением лаквинимода | |
AR082150A1 (es) | N-etil-n-fenil-1,2-dihidro-4-hidroxi-5-cloro-1-metil-2-oxoquinolin-3-carboxamida deuterada, sales y usos de la misma, metodo de tratamiento, mezcla compuestos, composicion farmaceutica, proceso de preparacion, compuesto enriquecido con deuterio | |
RU2016105581A (ru) | Способ лечения острого, хронического и подострого кашля и непреодолимого желания откашляться | |
BR112014008789A2 (pt) | prevenção e tratamento de condições oculares | |
EA201490163A1 (ru) | Ингибиторы кинуренин-3-монооксигеназы, фармацевтические композиции и способы их применения | |
BR112015029491A2 (pt) | derivados de imidazopirrolidinona e seu uso no tratamento de doença | |
EA201590902A1 (ru) | Способы и устройства, применяемые для лечения глазных болезней у человека | |
JP2014532654A5 (xx) | ||
BR112013027674A2 (pt) | "usos de composições de nanopartículas, composições compreendendo as referidas nanopartículas e cateter com uma agulha". | |
SMT201300095B (it) | Uso dell'estere etilico dell'acido eicosapentaenoico per trattare l'ipertrigliceridemia | |
EA201790406A1 (ru) | Ингибиторы кинуренин-3-монооксигеназы, фармацевтические композиции и способы их применения | |
NZ602635A (en) | Methods of enhancing drug delivery and effectiveness of therapeutic agents | |
PE20142319A1 (es) | Tratamiento de esclerosis multiple con combinacion de laquinimod y acetato de glatiramero | |
AR088585A1 (es) | Un medicamento para tratar la enfermedad del ojo anterior | |
BR112016015763B8 (pt) | preparação farmacêutica incluindo composto de ácido piridilaminocético, e, uso da mesma | |
AR094291A1 (es) | Formulacion inyectable de liberacion prolongada que comprende tolvaptan opticamente activo, y un procedimiento para producirla | |
BR112014031154A2 (pt) | agente profilático e/ou terapêutico para deficiência cognitiva leve; e agente de melhoria do fluxo intersticial | |
UA109642C2 (uk) | Композиція для лікування захворювань сітківки із застосуванням інтраокулярної тампонади |